Research work · 2021
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial
Bradley J. Monk, Nicoletta Colombo, Amit M. Oza, Keiichi Fujiwara, Michael J. Birrer, Leslie M. Randall, Elena V Poddubskaya, Giovanni Scambia, Yaroslav V. Shparyk, Myong Cheol Lim, Snehalkumar M Bhoola, Joohyuk Sohn, Kan Yonemori, Ross A. Stewart, Xiaoxi Zhang, Julia Perkins Smith, Carlos Linn, Jonathan Andrew Ledermann
The Lancet Oncology